Diabetes technology & therapeutics
-
Diabetes Technol. Ther. · Jun 2015
Multicenter Study Clinical TrialGlycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
The ProAct study has shown that a pump switch to the Accu-Chek(®) Combo system (Roche Diagnostics Deutschland GmbH, Mannheim, Germany) in type 1 diabetes patients results in stable glycemic control with significant improvements in glycated hemoglobin (HbA1c) in patients with unsatisfactory baseline HbA1c and shorter pump usage time. ⋯ Pump users who perform frequent daily glucose readings have a better glycemic control with lower glycemic variability.